Gene · 5355
PLP2: proteolipid protein 2
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. PLP2: proteolipid protein 2. Genes, record 5355. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5355
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q04941 | Proteolipid protein 2 | 152 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents33
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 60248 | Q04941 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 9760 | Q04941 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 3523 | Q04941 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 3523 | Q04941 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 9760 | Q04941 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 69586 | Q04941 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 2704 | Q04941 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 172557 | Q04941 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 8627 | Q04941 | Espacenet |
| US 11047010 B2 | 2021-06-29 | 3222 | Q04941 | Espacenet |
1 to 10 of 33
See all 33 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,112
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PLP2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA068485 | Cancer Center Support Grant | 5 | 2025 |
| P30DA018343 | Yale/NIDA Neuroproteomics Center | 5 | 2025 |
| R01MH077681 | Cholinergic Contribution to Circuits Guiding Behavioral Responses to Stressors | 5 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 4 | 2025 |
| R01AR077578 | Mechanisms of Cu-binding factors to promote myogenic gene expression | 4 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P01CA019014 | Viral Oncogenesis, Latency, and Replication | 2 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 2 | 2025 |
| P30CA023168 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 1,112Source NIH's project files
See all 1,112 nih grantsPapers1,588
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Ten-Gene Transcriptomic Biomarker Panel for Glioma Classification and Prognosis Identified via Integrative Hypergraph and Rough Set Analysis. | Cancers (Basel) | 2026 | 42192936 | PubTator, text mining | PubMed |
| Reduced YTHDF2 inhibits PD-L1 expression by stabilizing m6A-containing SPOP mRNA in colorectal cancer. | Cell Death Dis | 2026 | 41872151 | PubTator, text mining | PubMed |
| Selective Toxicity of Nicotinic Insecticides: Responsibility of Varied Amino Acid(s) in the Ligand-Docking Pocket between Insect versus Mammalian Nicotinic Acetylcholine Receptors. | Chem Res Toxicol | 2026 | 41785389 | PubTator, text mining | PubMed |
| Targeting tRNA-Arg-TCT-4-1 suppresses cancer cell growth and tumorigenesis. | bioRxiv | 2026 | 41757043 | PubTator, text mining | PubMed |
| Employing a Combination of Chemoattractants to Trap Glioblastoma Cells in a Macroporous Hydrogel. | Pharmaceutics | 2026 | 41754971 | PubTator, text mining | PubMed |
| Characterization of the Hydrogel-Binding Mechanism of Phellinus linteus Polysaccharides and Polymerized Whey Protein by SR-IR Technology and Its Application in Goat Milk Yogurt. | Foods | 2026 | 41750890 | PubTator, text mining | PubMed |
| Role of autophagy in antiviral innate immunity. | Cell Mol Biol Lett | 2026 | 41735833 | PubTator, text mining | PubMed |
| Epigenetically-controlled CEBPB regulates kidney cancer tumorigenesis via GPD1L-mediated ether lipid synthesis. | Cell Death Dis | 2026 | 41565622 | PubTator, text mining | PubMed |
Multiple sources of β2*-nicotinic acetylcholine receptor binding are differentially affected during tobacco smoking abstinence as revealed by Independent Component Analysis of [18F]Flubatine PET images. | Neuropsychopharmacology | 2026 | 41559453 | PubTator, text mining | PubMed |
| Discovery of a [4Fe-4S] cluster in the PRRSV Nsp1α leader protease reveals host-virus interplay in its downstream functions. | bioRxiv | 2026 | 41542491 | PubTator, text mining | PubMed |
1 to 10 of 1,588
See all 1,588 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5355
GET https://conductscience.org/api/genes/v1/5355/patents?page=2